Form 4: Maravai LifeSciences CFO Acquires Shares Through Employee Stock Purchase Plan

Maravai LifeSciences Holdings, Inc.'s Chief Financial Officer, Kevin Herde, acquired 876 shares of Class A Common Stock at $1.67 per share through the company's Employee Stock Purchase Plan.

Summary

• Kevin Herde, Chief Financial Officer of Maravai LifeSciences Holdings, Inc. (MRVI), acquired 876 shares of the company's Class A Common Stock.
• The acquisition took place on May 15, 2025, at a price of $1.67 per share.
• This transaction was made pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan (ESPP).
• Following this acquisition, Kevin Herde beneficially owns a total of 674,636 shares of Class A Common Stock.
• The acquisition of these shares is exempt under Rule 16b-3 of the Securities Exchange Act of 1934.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to an insider (CFO) acquiring shares, which can be interpreted as a sign of confidence in the company, even if it's through a routine employee plan.

Positives

• The acquisition of shares by a Chief Financial Officer, even through an ESPP, can signal management's confidence in the company's future prospects.
• Participation in the Employee Stock Purchase Plan demonstrates alignment of management's interests with those of shareholders.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• Kevin Herde, Chief Financial Officer, acquired 876 shares of Class A Common Stock through the company's 2020 Employee Stock Purchase Plan.

Industry Context

This filing is a routine insider transaction report, common for executives participating in company-sponsored stock purchase plans. Such transactions are standard disclosures required by the SEC to provide transparency on changes in beneficial ownership by company insiders.

Comparison to Industry Standards

• The acquisition of shares through an Employee Stock Purchase Plan (ESPP) is a common and standard benefit offered by many publicly traded companies across various industries to encourage employee ownership and alignment.
• The reporting of this transaction via Form 4 is standard practice for Section 16 officers and directors, aligning with regulatory requirements for transparency in insider holdings.

Related Party Transactions

• The acquisition of shares by Kevin Herde through the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan constitutes a transaction between an officer and the company.

Stakeholder Impact

• Shareholders: The acquisition by a key executive may be viewed as a positive signal of management's belief in the company's value, potentially fostering investor confidence.

Key Dates

Keywords

Maravai LifeSciences, MRVI, Form 4, Insider Transaction, Stock Acquisition, Kevin Herde, Chief Financial Officer, CFO, Employee Stock Purchase Plan, ESPP, Class A Common Stock